Moslosooflavone promotes diabetic wound healing via TrkB/PI3K-Akt signaling and macrophage polarization: in vitro and in vivo validation
Diabetic foot ulcers (DFUs) represent a severe and refractory diabetic complication characterized by persistent inflammatory activation, disordered macrophage phenotypic transformation, and impaired neurotrophic signaling. Although moslosooflavone (MOS) has been verified to possess anti-inflammatory and pro-healing bioactivities in multiple disease models, its underlying multi-target regulatory mechanisms in DFU wound repair remain poorly elucidated. Two public transcriptomic datasets (GSE134431, GSE199939) were integrated through weighted gene co-expression network analysis (WGCNA), protein–protein interaction(PPI) networks, and consensus machine learning (XGBoost (XGB), random forest (RF), LASSO regression, Boruta feature selection) to screen and validate core DFU-related targets. Potential MOS targets were predicted using SwissTargetPrediction, SEA, and TargetNet databases. Binding modes and stability were evaluated by molecular docking and 100-ns molecular dynamics (MD) simulations. Immune cell infiltration was quantified using CIBERSORT. In vitro, high-glucose-stimulated RAW264.7 macrophages were used to assess cell viability, cytokine secretion, phenotypic transformation, and pathway activation using CCK-8, ELISA, flow cytometry, RT-qPCR, and Western blotting. TrkB (K252a) and PI3K (LY294002) inhibitors were employed to confirm pathway dependency. In vivo, a streptozotocin-induced diabetic mouse full-thickness wound model received topical MOS-loaded Carbopol hydrogel. A five-gene diagnostic signature consisting of CYP1A1, MAOB, NTRK2, ESR2, and KIT exhibited high efficacy in distinguishing DFUs from normal skin tissues. Among these, CYP1A1, MAOB, and NTRK2 were prioritized as candidate MOS targets, displaying stable binding (-5.05 to -6.62 kcal/mol), sustained hydrogen bonds, RMSD < 0.5 nm, and favorable MM/PBSA free energies. These targets were functionally linked to M0/M2 macrophage homeostasis. In high-glucose-stimulated macrophages, MOS improved cell viability, suppressed pro-inflammatory cytokines, and promoted M2 polarization. Pharmacological blockade of TrkB and PI3K largely abrogated these protective effects, supporting an important role for the TrkB/PI3K-Akt axis in the observed effects of MOS. Topical MOS hydrogel dose-dependently accelerated diabetic wound closure, accompanied by increased infiltration of CD206 + M2 macrophages and elevated phospho-TrkB in F4/80 + wound macrophages. MOS facilitates diabetic wound repair via a dual regulatory mechanism. Specifically, MOS alleviates pathological oxidative damage and activates the TrkB/PI3K-Akt pro-healing signaling cascade.This synergistic dual regulation restores neurotrophic signaling homeostasis, resolves wound inflammatory microenvironment imbalance, and drives macrophage transformation into a reparative M2 phenotype, ultimately ameliorating DFU pathological progression and accelerating diabetic wound regeneration.
Authors
- Renying He
- Aijun Chen (ORCID: https://orcid.org/0009-0003-6198-2861)
- Sihong Xue
- Yanlin Yu
- Peiyu Wu
Institutions
- Army Medical University (CN)
- Dalian Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Emergency Medical Center (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1038/s41598-026-69638-5
- Primary Topic
- Wound Healing and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Chongqing